跳至主要内容
临床试验/NCT05053568
NCT05053568进行中(未招募)不适用

Advanced Image Supported Lead Placement in Cardiac Resynchronization Therapy

UMC Utrecht8 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2021年2月8日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
UMC Utrecht
入组人数
130
试验地点
8
主要终点
Differences in % of patients with succesfull LV lead location

研究概览

简要总结

Cardiac resynchronization therapy (CRT) is an established pacemaker therapy for patients with symptomatic chronic heart failure, but is hampered by a non-response rate of 30-40%. Optimising left ventricular (LV) lead placement is the cornerstone of improving treatment. The optimal location for the lead is remote from scar but within segments demonstrating late electromechanical activation. The present study aims to investigate the efficacy and clinical effect of the use of real-time guided lead placement using cardiac MRI and fluoroscopy in a blinded, multicenter, randomized controlled trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Heart failure with LV ejection fraction ≤ 35%;
  • New York Heart Association class II, III, or IV (ambulatory);
  • Optimal medical treatment that is tolerable;
  • Left bundle branch block (LBBB) and QRS ≥ 130 ms, OR non-LBBB and QRS ≥ 150 ms.

排除标准

  • Pregnancy or lactation;
  • Subjects with impaired renal function (severe renal insufficiency, GFR < 30 ml/min/1.73m2);
  • Atrial fibrillation or atrial fibrillation during MRI
  • Documented allergic reaction to gadolinium;
  • Impossibility to undergo an MRI scan;
  • Participation in another clinical study that prohibits any procedures other than standard.

结局指标

主要结局

Differences in % of patients with succesfull LV lead location

时间窗: Direct post-CRT

Lead location, defined as being within, adjacent, or remote from the pre-defined target.

次要结局

  • Change in Kansas City Cardiomyopathy Questionnaire(6, 12 and 24 months)
  • Change in EQ-5D-5L(6, 12 and 24 months)
  • Change in reverse remodelling and volumetric response(6 months)
  • Health Technology Assessment(24 months)
  • Change in CRT response score(12 months)

研究者

发起方
UMC Utrecht
申办方类型
Other
责任方
Principal Investigator
主要研究者

M. Meine

Principal Investigator (MD, PhD)

UMC Utrecht

研究点 (8)

Loading locations...

相似试验